Bionano Genomics Inc Registered Shs Stock , BNGO

5.75 +0.02 +0.35%

Pre-market 07:42:13 AM NAS

Plus500. 72% of retail CFD accounts lose money

5.73 -0.15 -2.55%

Official Close 8/30/2021 NAS

Loading..
Date Open Close Daily High Daily Low

Price change over selected period: 0% 0

Total Analysts: 3

Buy Ratings: 2 Neutral Ratings: 1 Sell Ratings: 0

Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}

Price *Price Target

Lowest: 1.25 Median: 4.25 Highest: 10.00

  • All
  • Buy
  • Hold
  • Sell
  2021 2022 2023 2024 2025
Revenue 16 28 53 109 208
Dividend - - - - -
Dividend Yield (in %) - - - - -
EPS -0.22 -0.23 -0.22 -0.14 0.03
P/E Ratio -26.30 -25.22 -27.06 -43.23 196.95
EBIT -61 -66 -62 -39 9
EBITDA -60 -66 -65 - -
Net Profit -62 -66 -62 -39 9
Net Profit Adjusted -64 -84 -95 -104 -103
Pre-Tax Profit -61 -60 -51 -7 121
Net Profit (Adjusted) - - - - -
EPS (Non-GAAP) ex. SOE -0.23 -0.30 -0.34 -0.37 -0.37
EPS (GAAP) -0.23 -0.25 -0.23 -0.15 0.03
Gross Income 7 13 29 74 154
Cash Flow from Investing - - - - -
Cash Flow from Operations - - - - -
Cash Flow from Financing - - - - -
Cash Flow per Share - - - - -
Free Cash Flow - - - - -
Free Cash Flow per Share - - - - -
Book Value per Share - - - - -
Net Debt - - - - -
Research & Development Exp. 17 23 27 29 34
Capital Expenditure - - - - -
Selling, General & Admin. Exp. 51 57 65 80 110
Shareholder’s Equity 6 - - - -
Total Assets 28 - - - -
  Previous Quarter
ending 06/30/21
Current Quarter
ending 09/30/21
Next Quarter
ending 12/31/21
Current Year
ending 12/31/21
Next Year
ending 12/31/22
Earnings Estimates
No. of Analysts 4 4 4 4 4
Average Estimate -0.045 USD -0.058 USD -0.061 USD -0.225 USD -0.234 USD
Year Ago -0.090 USD -0.080 USD -0.070 USD -0.390 USD -0.225 USD
Publish Date 8/4/2021 11/11/2021 3/17/2022 - -
Revenue Estimates
No. of Analysts 4 4 4 4 4
Average Estimate 4 USD 4 USD 5 USD 16 USD 28 USD
Year Ago 1 USD 2 USD 4 USD 9 USD 16 USD
Publish Date 8/4/2021 11/11/2021 3/17/2022 - -

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

*Price and Yield of the Respective Date

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

Risk

  • Low
  • Medium
  • High

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Owner in %
Freefloat 99.66
Legend Capital Co. Ltd. 10.97
Innovatus Capital Partners LLC 5.11
Vanguard Group, Inc. (Subfiler) 5.04
Hung Ka Kung 3.68
Renaissance Technologies LLC 3.40
BlackRock Fund Advisors 3.28
Vanguard Total Stock Market Index Fund 2.82
State Street Corp. 2.70
BlackRock Institutional Trust Co. NA 2.53
Geode Capital Management LLC 1.68
Vanguard Extended Market Index Fund 1.43
Invesco Dwa Healthcare Momentum Etf 1.39
Millennium Management LLC 1.15
Bank Julius Bär & Co. AG 0.97

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Say hello

Find us at the office

Chappa- Adamitis street no. 38, 81811 Tripoli, Libya

Give us a ring

Alda Runion
+69 213 130 910
Mon - Fri, 10:00-22:00

Say hello